Pharma News

HotSpot Therapeutics to Present Preclinical Data from Small Molecule CBM Signalosome Inhibitor Program at ESMO Gastrointestinal Cancers Congress 2025

The WHO Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), a panel of 27 independent, international, multidisciplinary experts, today published its report on the origins of S...

UK's medicines regulatory body has seized nearly eight million doses of illegal medicines as part of an annual global coordinated operation to tackle the illegal online sale of medicines and medic...

Kymera’s programme focuses on removing CDK2 from cells compared to other therapies that target the protein’s inhibition.

Cellectar Biosciences, Inc., a clinical-stage biotech company with a market capitalization of $14 million, released an update Thursday

Amyvid is a drug used for brain PET to assess the density of amyloid beta neuritic plaques in adults experiencing cognitive impairment for Alzheimer’s evaluation.

Lupin received USFDA approval for Prucalopride tablets used in chronic constipation treatment. Lupin’s March quarter revenue rose by 12.2% to ₹5,567.1 crore.

Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Coll...

Sotyktu (Deucravacitinib) met its primary endpoint of more than 20% improvement in ACR20 response among patients with psoriatic arthritis in the POETYK PsA-1 study

InMed Pharmaceuticals Inc.  stock doubled on Tuesday following the announcement of promising preclinical data for its Alzheimer’s disease drug candidate INM-901.

Researchers at the University of Pennsylvania have transformed the toxic fungus Aspergillus flavus into a potent cancer-fighting compound that destroys tumors.

Olive oil has long been known for its role in the Mediterranean diet and its many health benefits. Now,